David Champagne has been promoted to vice president and general manager of the informatics business of Thermo Electron, the company said last week. He succeeds Jo Webber, who left the company. Champagne joined Thermo in 2003 and was most recently its divisional commercial director. In the past, he held positions at Lotus Development and early-stage software companies.
Thomas Caskey has joined the board of directors of MDS, which operates a joint venture in mass spectrometry with Applied Biosystems. Caskey is a managing director of Cogene BioTech Ventures. In the past, he was chairman of the department of molecular and human genetics of Baylor College of Medicine, senior vice president of human genetics and vaccines discovery at Merck Research Laboratories, president of the Merck Genome Research Institute, president of the American Society of Human Genetics, and president of the Human Genome Organization.
Additionally, MDS last week named Stephen DeFalco as COO, effective June 6. DeFalco will replace John Rogers, who plans to retire as president and CEO by the end of 2005, the company said. DeFalco was been chairman and CEO of US Genomics since 2003. Prior to US Genomics, he was president of the instruments arm of PerkinElmer.
Millenia Hope of Montreal said last week that Margaret Bywater has joined the company as president. Bywater was previously vice president of business development and licensing at H3 Pharma. She formerly was corporate staff vice president for pharmaceutical business development for PerkinElmer, and general manager of the company's GenScope unit. She also worked for Pharmacia.
James Hayden last week was named senior vice president of global sales for Mountain View, Calif.-based Pharsight. He joined the company from Accelrys, where he was national director of sales. Previously, he was a sales representative for Bio-Rad Laboratories.